CapsoVision, Inc SEC filings CV

CapsoVision, Inc has 141 filings in SEC EDGAR's recent list, going back to Oct 10, 2006. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (other events). The company's fiscal year ends on December 31.

CapsoVision, Inc SEC filings
Form Description Filed Period
424B5 Prospectus supplement Sep 18, 2026 —
424B5 Prospectus supplement Aug 21, 2026 —
S-3 Shelf registration Aug 13, 2026 —
424B3 Prospectus Apr 23, 2026 —
S-1 Registration statement Apr 17, 2026 —
S-8 Employee stock plan registration Jul 10, 2025 —
424B4 Prospectus Jul 3, 2025 —
S-1/A Amended registration statement Jun 27, 2025 —
S-1/A Amended registration statement Jun 13, 2025 —
FWP Free writing prospectus Jun 2, 2025 —
S-1/A Amended registration statement May 30, 2025 —
S-1 Registration statement May 9, 2025 —

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
CV (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Saratoga, CA
SEC filer status
, Emerging growth company
SEC CIK
1378325
Former names
Capso Vision Inc (until Feb 21, 2014)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.